Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus-Coinfected Subjects With Hepatic Impairment-Reference-Cited by-同舟云学术

Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus-Coinfected Subjects With Hepatic Impairment

Published:2006-03 Issue:3 Volume:46 Page:265-274
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Peng Joanna Z.,Pulido Federico,Causemaker Sonja J. Kemmis,Li Jianling,Lorenzo Alicia,Cepeda Concepción,Cabanillas Juan A. García,DaSilva Barbara,Brun Scott C.,Arribas José

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group;Sherman;Clin Infect Dis,2002

2. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival;Staples;Clin Infect Dis,1999

3. Koch J Kim LS Friedman S Gastrointestinal manifestations of HIV Peiperl L Coffey S Volberding P HIV InSite Knowledge Base [online textbook] University of California http://hivinsite.ucsf.edu/InSite?page=kb-04-01-11#S10.1X

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era;Journal of VitreoRetinal Diseases;2023-11-09

2. Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID‐19;The Journal of Clinical Pharmacology;2023-10-24

3. The use of text mining to obtain a historical overview of research on therapeutic drug monitoring;2023-06-29

4. Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management;Frontiers in Pharmacology;2022-11-28

5. Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir;The Journal of Clinical Pharmacology;2021-01-18